When Cuts Cost More: Projected Fiscal Impact of Eliminating the AIDS Drug Assistance Program in 30 US States
Forster, R. M.; Schnure, M.; Balasubramanian, R.; Jones, J. L.; Hyle, E. P.; Batey, S.; Althoff, K. N.; Gebo, K.; Dowdy, D.; Shah, M.; Fojo, A. T.; Kasaie, P.
Show abstract
Across 30 US states and the District of Columbia, eliminating the AIDS Drug Assistance Program is projected to save $6.45 billion in direct costs while generating $14.89 billion in downstream HIV care costs attributable to excess incident infections from 2026-2035. Costs are projected to surpass savings within six years.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Trends in HIV self-testing uptake in Africa: a modeling study of population-based surveys and HIV testing program data 91%
- Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants 90%
- Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: an individual-based modelling study 89%
Similar papers in this journal
- The Risks and Benefits of Providing HIV Services during the COVID-19 Pandemic 92%
- Impact Of The COVID-19 Pandemic On Routine HIV Care And Antiretroviral Treatment Outcomes In Kenya: A Nationally Representative Analysis 92%
- A novel use of HIV surveillance and court data to understand and improve care among a population of people with HIV experiencing criminal charges in North Carolina 2017-2020 92%
Similar papers in this journal
- A Decision Analytics Model to Optimize Investment in Interventions Targeting the PrEP Cascade of Care 94%
- A Moving Target: Impacts of Lowering Viral Load Suppression Cutpoints on Progress Towards HIV Epidemic Control Goals 93%
- National HIV testing and diagnosis coverage in sub-Saharan Africa: a new modeling tool for estimating the \"first 90\" from program and survey data 93%
Similar papers in this journal
- Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe 92%
- The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia 91%
- Optimizing next-generation RSV prevention in Mali: a cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis 89%
Similar papers in this journal
- Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study 90%
- Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes 90%
- Single-dose effectiveness of mpox vaccine in Quebec, Canada: test-negative design with and without adjustment for self-reported exposure risk 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.